This inventor holds 1 USPTO granted patent. Top assignees: Itto Denko Corporation, Nikken Chemicals Co., Ltd.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Innovations by Shigeyuki Watanabe
Introduction
Shigeyuki Watanabe is a notable inventor based in Osaka, Japan. He is recognized for his contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work has led to advancements that enhance the efficacy of pain management therapies.
Latest Patents
Watanabe holds a patent for a percutaneous absorption preparation. This preparation is designed to improve the skin penetration of the non-narcotic analgesic buprenorphine. It allows for sustained high blood levels of the drug over an extended period. The formulation includes a plaster layer containing a pressure-sensitive adhesive, buprenorphine hydrochloride, and a penetration enhancer. The penetration enhancer is a combination of a monoglyceride of a fatty acid with 6 to 8 carbon atoms and isopropyl myristate. This innovative approach significantly elevates the skin penetration of buprenorphine.
Career Highlights
Throughout his career, Watanabe has worked with prominent companies in the pharmaceutical industry. He has been associated with Itto Denko Corporation and Nikken Chemicals Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.
Collaborations
Watanabe has collaborated with notable colleagues, including Shoichi Tokuda and Kazuhisa Ninomiya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Shigeyuki Watanabe's contributions to pharmaceutical innovations, particularly in drug delivery systems, have made a significant impact in the field. His patent for a percutaneous absorption preparation exemplifies his commitment to improving patient care through effective pain management solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile